17
Participants
Start Date
July 23, 2024
Primary Completion Date
October 5, 2024
Study Completion Date
October 5, 2024
AZD6793
Participants will receive single dose of AZD6793 on Day 1 in Period 1 and on Day 8 in combination with itraconazole in Period 3.
Itraconazole
Participants will receive 2 doses of itraconazole on Day 4 and single dose from Day 5 to Day 7 in Period 2. On Day 8 participants will receive single dose of itraconazole combined with AZD6793 and then single dose of itraconazole from Day 9 to Day 10 in Period 3.
AZD6793+ Itraconazole
Participants will receive a combined dose of AZD6793 and itraconazole on Day 8 in Period 3.
Research Site, Berlin
Lead Sponsor
AstraZeneca
INDUSTRY